KYMERA THERAPEUTICS, INC. Earnings Per Share, Basic and Diluted
KYMERA THERAPEUTICS, INC. (KYMR) reported Earnings Per Share, Basic and Diluted of -$0.71 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-03.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-03
- KYMERA THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.71.
- KYMERA THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.66.
- KYMERA THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.56.
- KYMERA THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.55.
- KYMERA THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2021 was -$2.09.
- KYMERA THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2020 was -$3.15.
- KYMERA THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2019 was -$24.28.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.71 10-Q · filed 2022-05-03 | -$1.37 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$1.93 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$2.49 derived: net income ÷ weighted average shares · filed 2024-02-22 |
| 2021-12-31 | -$0.66 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$1.22 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$1.78 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$2.09 10-K · filed 2022-02-24 |
| 2021-09-30 | -$0.56 10-Q · filed 2021-11-10 | -$1.11 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$1.42 10-Q · filed 2021-11-10 | -$1.71 derived: net income ÷ weighted average shares · filed 2023-02-23 |
| 2021-06-30 | -$0.55 10-Q · filed 2021-08-06 | -$0.84 10-Q · filed 2021-08-06 | -$1.12 derived: net income ÷ weighted average shares · filed 2023-02-23 | -$1.51 derived: net income ÷ weighted average shares · filed 2023-02-23 |
| 2021-03-31 | -$0.29 10-Q · filed 2022-05-03 | -$0.58 derived: net income ÷ weighted average shares · filed 2023-02-23 | -$0.92 derived: net income ÷ weighted average shares · filed 2023-02-23 | -$1.70 derived: net income ÷ weighted average shares · filed 2023-02-23 |
| 2020-12-31 | -$0.28 derived: net income ÷ weighted average shares · filed 2023-02-23 | -$0.63 derived: net income ÷ weighted average shares · filed 2023-02-23 | -$1.54 derived: net income ÷ weighted average shares · filed 2023-02-23 | -$3.15 10-K · filed 2022-02-24 |
| 2020-09-30 | -$0.39 10-Q · filed 2021-11-10 | -$1.94 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$5.11 10-Q · filed 2021-11-10 | -$8.07 derived: net income ÷ weighted average shares · filed 2022-02-24 |
| 2020-06-30 | -$6.98 10-Q · filed 2021-08-06 | -$17.18 10-Q · filed 2021-08-06 | -$23.39 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$30.03 derived: net income ÷ weighted average shares · filed 2022-02-24 |
| 2020-03-31 | -$10.23 10-Q · filed 2021-05-06 | -$16.44 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$23.09 derived: net income ÷ weighted average shares · filed 2022-02-24 | |
| 2019-12-31 | -$6.13 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$12.66 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$24.28 10-K · filed 2022-02-24 | |
| 2019-09-30 | -$6.54 10-Q · filed 2020-11-05 | -$18.15 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |